WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today announced the election of Pfizer Chairman and CEO Jeffrey B. Kindler to BIO’s Board of Directors. Kindler will replace Pfizer Vice President of Corporate Policy and Strategic Management Fred Telling, who had served on the BIO Board for eleven years and is retiring from Pfizer this year.
